CatalYm

Series-B+
catalym.com Biotech & Healthcare Martinsried, Germany 11-50
Total Funding $259.0M
Latest Round $150M Series-B+
Last Announced Jul 16, 2024
Investors 13 Backers
Decision Makers 6 Verified

About CatalYm

CatalYm develops immune therapies for solid tumors. It identifies GDF-15 as a key cancer therapy resistance mechanism and aims to neutralize it. CatalYm's lead antibody, Visugromab, is in clinical trials for patients with relapsed and refractory metastatic solid tumors. The company focuses on advancing its therapies through clinical development.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Martinsried, Germany
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website catalym.com
Domain Registered Date Jul 18, 2016

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $150,000,000 · Series-B+

    fundraisingfox.com

  2. Capital Raise

    Raised $50,000,000 · Series-B+

  3. Capital Raise

    Raised $59,040,000 · Series-B+

  4. Milestone

    Website domain registered

    catalym.com

Investors & Backers

13
Bayern Kapital
BioGeneration Ventures
Bioqube Ventures
Brandon Capital
Canaan Partners
coparion
Forbion Capital Partners
Gilde Healthcare
Jeito Capital
Novartis Venture Fund
Omega Funds
Vesalius Biocapital Partners
Wachstumsfonds Bayern

Funding History

3 Rounds
Series-B+ · Jul 16, 2024
Series-B+ · Nov 22, 2022
$50,000,000 Source
Series-B+ · Nov 10, 2020
$59,040,000 Source

Founders & Leadership

8

Andrea Goddard

Chief Technology Officer

Work email & phone locked Unlock →

Anne Burger

CFO

Work email & phone locked Unlock →

Christine Schuberth Wagner

Chief Scientific Officer (CSO)

Work email & phone locked Unlock →

Clinton Musil

Chief Financial Officer and Chief Business Officer

Work email & phone locked Unlock →

Jörg Wischhusen

Founder

Work email & phone locked Unlock →

Peter Garcia

Chief Financial Officer

Work email & phone locked Unlock →

Phil L’Huillier

Managing Director and Chief Executive Officer (CEO)

Work email & phone locked Unlock →

Sujata Rao

Chief Medical Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts